Pegaptanib Sodium
Generic Name: pegaptanib sodium
Manufactured by BAUSCH AND LOMB INC. Dosage form: INJECTABLE. Route: INTRAVITREAL. Active ingredients: PEGAPTANIB SODIUM (EQ 0.3MG ACID/0.09ML). Application: NDA021756.
Overview
Manufactured by BAUSCH AND LOMB INC. Dosage form: INJECTABLE. Route: INTRAVITREAL. Active ingredients: PEGAPTANIB SODIUM (EQ 0.3MG ACID/0.09ML). Application: NDA021756.
Dosage
Available as injectable for intravitreal use.
Related Medications
Canagliflozin
canagliflozin
11 DESCRIPTION INVOKANA ® (canagliflozin) contains canagliflozin, an inhibitor of SGLT2, the transporter responsible for reabsorbing the majority of glucose filtered by the kidney. Canagliflozin, the active ingredient of INVOKANA, is chemically known as (1 S )-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol hemihydrate and its molecular formula and weight are C 24 H 25 FO 5 S∙1/2 H 2 O and 453.53, respectively.
Meglumine
meglumine
Dosage form: POWDER. Active ingredients: MEGLUMINE (1 kg/kg). Category: BULK INGREDIENT.
Rilzabrutinib
rilzabrutinib
Kinase Inhibitor [EPC]
11 DESCRIPTION WAYRILZ (rilzabrutinib) is a kinase inhibitor. Rilzabrutinib is a white to off-white solid, which is freely soluble in ethanol, sparingly soluble in isopropyl alcohol and practically insoluble in water. The chemical name for rilzabrutinib is 1-Piperidinepropanenitrile, 3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1 H -pyrazolo[3,4- d ]pyrimidin-1-yl]-α-[2-methyl-2-[4-(3-oxetanyl)-1-piperazinyl]propylidene]-β-oxo-, (3 R )-.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.